David Liu of Sonde Health on Vocal Biomarkers - Voicebot Podcast Ep 264 episode artwork

EPISODE · Jul 23, 2022 · 1H 8M

David Liu of Sonde Health on Vocal Biomarkers - Voicebot Podcast Ep 264

from The Voicebot Podcast · host Bret Kinsella

David Liu is CEO of Sonde Health, a company using vocal biomarkers to assess patient health, wellness, and fitness. The company is white labeling its solution for app developers with initial products for respiratory and mental health problems.  In the interview, Liu discusses the product, technology, and key markets serving as the first adopters. These include healthcare providers and payers along with one industry I wasn't expecting.  Liu has been CEO of Sonde Health since 2019. He previously was chief operating officer at Quartet Health and education technology company Knewton and was a senior vice president at AOL. He earned an engineering degree from Purdue and an MBA from Columbia.

Episode metadata supplied by the publisher feed · Published Jul 23, 2022

Embed this episode

NOW PLAYING

David Liu of Sonde Health on Vocal Biomarkers - Voicebot Podcast Ep 264

0:00 1:08:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Voicebot Podcast?

This episode is 1 hour and 8 minutes long.

When was this The Voicebot Podcast episode published?

This episode was published on July 23, 2022.

Can I download this The Voicebot Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!